Share your experience to improve the Australian COVID-19 Clinical Guidelines

[ACIPC Office]

Dear ACICP Members,

The National COVID-19 Clinical Evidence Taskforce is running its second clinician impact survey.

The Taskforce wants to identify strengths and opportunities for improvement in the work of the Taskforce and their guidelines and flowcharts.

Australian healthcare practitioners are invited to participate in a brief 5-minute survey.

Participation is voluntary, anonymous, and very much appreciated.

Click here to submit your feedback before Monday 7 December.

Thanks all!

Kind regards,
Sara Kirby
[ACIPC_Logo_Colour_RGB]
Australasian Office Manager
+61 3 6281 9234
0429 294 033
officemanager@acipc.org.au
https://www.acipc.org.au
228 Liverpool Street, Hobart TAS 7000, Australia
[cid:image002.jpg@01D6C980.0C852EA0]

MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au

To send a message to the list administrator send an email to admin@acipc.org.au

You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au

[Author]

Posts